ML19239A096
| ML19239A096 | |
| Person / Time | |
|---|---|
| Issue date: | 07/24/2019 |
| From: | Advisory Committee on the Medical Uses of Isotopes |
| To: | |
| Jamerson, Kellee NMSS | |
| References | |
| Download: ML19239A096 (4) | |
Text
TELECONFERENCE MEETING OF THE ADVISORY COMMITTEE ON THE MEDICAL USES OF ISOTOPES July 24, 2019 MEETING
SUMMARY
PURPOSE To discuss the U.S. Nuclear Regulatory Commission (NRC) Abnormal Occurrence Criteria and the Advisory Committee on the Medical Uses of Isotopes (ACMUI) subcommittees report on a draft guidance document.
OUTCOME The ACMUI discussed whether the current abnormal occurrence criteria provide an appropriate threshold for determining if an incident or event is significant from the standpoint of public health and safety or whether the criteria should be revised. The NRC staff gained a better understanding of the views and opinions of the Committee. The NRC staff will consider the Committees comments in the development of its notation vote paper to the Commission.
A full transcript and handout for the open session of the ACMUI teleconference meeting can be found on the NRCs public web site at: http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/.
AGENDA TOPICS Discuss the NRCs Abnormal Occurrence Criteria Discuss the ACMUI Subcommittees report on a draft guidance document
SUMMARY
The ACMUI discussed the existing NRC AO criteria, including the revisions to the policy statement on reporting abnormal occurrences to Congress that were incorporated in 2017.
RECOMMENDATIONS AND ACTIONS The ACMUI provided the following recommendation with respect to the NRCs Abnormal Occurrence criteria:
The current medical event abnormal occurrence criteria are not appropriate and need to be reviewed and revised.
The recommendation passed unanimously with thirteen votes. The NRC staff will incorporate the Committees recommendation into its notation vote paper to the Commission.
Enclosures:
- 1. Meeting Attendees
- 2. Teleconference Agenda
MEETING ATTENDEES ACMUI Christopher J. Palestro, M.D. Chairman Darlene F. Metter, M.D. Vice Chairman Vasken Dilsizian, M.D. Member Richard Green Member Melissa Martin Member Michael D. OHara, M.D. Member Zoubir Ouhib Member A. Robert Schleipman, Ph.D. Member Michael Sheetz Member Megan Shober Member Laura Weil Member Harvey B. Wolkov, M.D. Member NRC Kevin Williams Deputy Director, Division of Materials Safety, Security, State, and Tribal Programs (MSST)
Vincent Holahan Senior Level Advisor, MSST Lisa Dimmick Designated Federal Officer, Medical Radiation Safety Team Leader, NMSS/MSST/MSEB Kellee Jamerson Designated Federal Officer/ACMUI Coordinator/MSEB Maryann Ayoade NMSS/MSST/MSEB Sophie Holiday NMSS/MSST/MSEB Ian Irvin OGC/GCLR/RMR Cynthia Jones OCM/AXC Vered Shaffer RES/DSA/RPB Katherine Tapp, Ph.D. NMSS/MSST/MSEB John Tomon RES/DSA/RPB Alexus Willis RES/DE/CMB MEMBERS OF THE PUBLIC Jaime Barnes Cook Childrens Medical Center Ariel Doucet Virtua Health Sherrie Flaherty Minnesota Radioactive Materials Unit Stanley Hampton Eli Lilly Miguel de la Guardia Cook Childrens Medical Center Ralph Lieto St. Joseph Mercy Health System Carol Marcus, Ph.D, M.D. University of California at Los Angeles (UCLA)
Michael Peters American College of Radiology Andrew Najjar Harvard Medical School, Boston Childrens Hospital Aria Razmaria, M.D. UCLA Medical Center Cindy Tomlinson American Society of Radiation Oncology Matthew Williams Georgetown University Melonie Wissing Virginia Office of Radiological Health Enclosure 1
Advisory Committee on the Medical Uses of Isotopes TELECONFERENCE AGENDA Wednesday, July 24, 2019 10:00 AM - 12:00 PM (ET)
OPEN SESSION 10:00 AM - 10:30 AM Discuss the NRCs Abnormal Occurrence Criteria CLOSED SESSION 10:30 AM - 12:00 PM Discuss the ACMUI Subcommittees report on a draft guidance document Enclosure 2